John David Martin - Feb 24, 2022 Form 3 Insider Report for Butterfly Network, Inc. (BFLY)

Role
Chief Medical Officer
Signature
/s/ Mary Miller, Attorney-in-Fact
Stock symbol
BFLY
Transactions as of
Feb 24, 2022
Transactions value $
$0
Form type
3
Date filed
3/4/2022, 05:02 PM
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BFLY Class A Common Stock 38.9K Feb 24, 2022 Direct F1
holding BFLY Class A Common Stock 7.98K Feb 24, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BFLY Stock Option (right to buy) Feb 24, 2022 Class A Common Stock 519K $1.77 Direct F2, F3
holding BFLY Stock Option (right to buy) Feb 24, 2022 Class A Common Stock 41.5K $9.40 Direct F4, F5
holding BFLY Stock Option (right to buy) Feb 24, 2022 Class A Common Stock 62.3K $9.40 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over four years beginning on February 11, 2022, subject to Dr. Martin's continued service through the applicable vesting date. In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of November 19, 2020, by and among Longview Acquisition Corp. ("Longview"), Clay Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Longview ("Merger Sub"), and Butterfly Network, Inc., a Delaware corporation ("Butterfly"), pursuant to which Merger Sub merged with and into Butterfly (the "Merger"), with Butterfly surviving as a wholly-owned subsidiary of Longview (which changed its name to "Butterfly Network, Inc.", the "Issuer"), these shares were received in exchange for 50,000 RSUs of Butterfly.
F2 The shares underlying this option are fully vested.
F3 Received in connection with the Merger in exchange for a stock option to acquire 500,000 shares of Butterfly common stock for $1.83 per share.
F4 The shares underlying this option vest in equal monthly installments over 48 months beginning on January 31, 2021, subject to Dr. Martin's continued service through the applicable vesting date.
F5 Received in connection with the Merger in exchange for a stock option to acquire 40,000 shares of Butterfly common stock for $9.75 per share.
F6 The shares underlying this option vest in equal monthly installments over 48 months beginning on January 31, 2021, subject to Dr. Martin's continued service through the applicable vesting date.
F7 Received in connection with the Merger in exchange for a stock option to acquire 60,000 shares of Butterfly common stock for $9.75 per share.

Remarks:

Exhibit 24.1 - Power of Attorney